"Our study used a methodically rigorous process to identify biomarkers, and we believe this represents the first study to select biomarkers for Barrett's esophagus, esophageal adenocarcinoma and ...
Recent American Gastroenterological Association guidelines support the treatment of confirmed low-grade dysplasia. Ablation of non-dysplastic Barrett's esophagus may be appropriate in high-risk ...
Extending the ability to identify healthy control patients versus patients with Barrett’s esophagus and high-grade dysplasia or esophageal cancer combined, the AUC was 0.86, which Meltzer says ...
Today, Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of Esopredict®, the only ...
People with Barrett’s oesophagus usually have regular endoscopies to monitor it. The team take small tissue samples (biopsies). They look for early changes in the cells. This is called dysplasia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results